Bioatla investor relations
WebNov 4, 2024 · November 04, 2024 — 12:15 pm EDT. BioAtla, Inc. (BCAB) came out with a quarterly loss of $0.69 per share versus the Zacks Consensus Estimate of a loss of $0.77. This compares to loss of $0.68 ... WebApr 16, 2024 · About BioAtla, LLC. BioAtla is a global clinical-stage biotechnology company with operations in San Diego, California, and Beijing, China. BioAtla develops novel monoclonal antibody and other ...
Bioatla investor relations
Did you know?
WebApr 3, 2024 · Investor FAQs; Email Alerts; Contact IR; SEC Filings Group. Filing year. Items per page. Filing date Form Description Filing Group View; 04/03/23: 4: Statement of changes in beneficial ownership of securities. 3,4,5. 0001209191-23-022427.pdf. 0001209191-23-022427.rtf ... BioAtla ® is a leading San ... WebEdit. BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise Mecbotamab vedotin, Ozuriftabmab vedotin, BA3071, and Bispecific antibody programs.
WebThe generative AI drug company ramps up its internal pipeline and R&D portfolio, tapping into European markets, talent, and tech VANCOUVER, Wash. and NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced its expansion. 21 Feb / 23. WebMar 25, 2024 · Net loss for the full year ended December 31, 2024 was $35.9 million compared to a net loss of $29.8 million for the year 2024. About BioAtla, Inc. BioAtla is a global clinical-stage biotechnology ...
WebMay 12, 2024 · BioAtla, Inc. May 12, 2024, 18:26 ET. SAN DIEGO, May 12, 2024 /PRNewswire/ -- BioAtla, Inc. (Nasdaq: BCAB ), a global clinical-stage biotechnology … WebBioAtla, Inc. 11085 Torreyana Road . San Diego, California, 92121 ... presentations, webcasts and our investor relations website. While not all of the information that we …
WebAug 17, 2024 · BioAtla is not a large company by global standards. It has a market capitalization of US$445m, which means it wouldn't have the attention of many institutional investors.
WebMay 12, 2024 · BioAtla, Inc. May 12, 2024, 18:26 ET. SAN DIEGO, May 12, 2024 /PRNewswire/ -- BioAtla, Inc. (Nasdaq: BCAB ), a global clinical-stage biotechnology company focused on the development of ... flying time to malta from ukWebAug 9, 2024 · Forward-looking statements contained in this press release are made as of this date, and BioAtla undertakes no duty to update such information except as required … flying tire bicycle weatherfordWebApr 6, 2024 · PFIZER INC. : Presentación de la compañía PFIZER INC., accionistas, dirección, descripción del negocio, calificaciones financieras, comunicados de prensa oficiales, detalles de contacto y códigos de la bolsa de valores PFE US7170811035 Bulgaria Stock Exchange green mountain cloggersWebDec 16, 2024 · In addition, BioAtla has granted the underwriters a 30-day option to purchase up to an additional 1,575,000 shares of common stock at the initial public offering price, less underwriting discounts ... green mountain club burlington sectionWebMar 24, 2024 · BioAtla, Inc. (NASDAQ:NASDAQ:BCAB) Q4 2024 Earnings Call Transcript March 23, 2024 4:30 PM ETCompany ParticipantsBruce Mackle - Investor Relations, … green mountain clubWebBioAtla ® is a leading San Diego-based biopharmaceutical company developing safer and more effective drugs for cancer. Its Conditionally Active Biologics ™ (CAB) platform … flying tippler society of usaWebJan 10, 2024 · The Investor Relations website contains information about BioAtla, Inc's business for stockholders, potential investors, and financial analysts. flying tire custom baggers